STOCK TITAN

LiqTech International (LIQT) Financials

LIQT NASDAQ
Trailing 12 months to September 30, 2026
Revenue $16.0M -4.6% YoY
Net Income -$10.2M n/m YoY
Free Cash Flow -$8.5M YoY not available
Operating Cash Flow -$8.0M n/m YoY
Market Cap $6.4M as of Nov 20, 2026
Price / Sales 0.4x on $16.0M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 0.3x on $24.3M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LIQT SEC filings page.

LiqTech International, Inc. (LIQT) reported $16.0M in revenue over the twelve months to Sep 30, 2026, down 4.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LIQT FY2025

LiqTech’s 2025 sales and gross margin recovered, but fixed operating costs still left each revenue dollar far from profitability.

The gross-margin rebound was not enough to change the business economics: gross margin improved from 1.7% to 7.6% in FY2025. That recovery did not reach operating earnings, with operating margin still at -50.3% while SG&A consumed 50.9% of revenue.

In FY2025, net loss was $8.5M while operating cash flow was -$6.1M, so the cash outcome remained broadly aligned with the accounting loss rather than being mainly non-cash. With capital expenditures of $395K, free cash flow was -$6.5M, indicating the shortfall was primarily operating rather than a heavy reinvestment burden.

The balance sheet became more burdened by liabilities: they represented 62.0% of assets in FY2025 while total equity fell 37.4% from FY2024. Meanwhile, inventory rose 16.9% and receivables 43.2%, suggesting more resources were tied up in goods and customer balances as revenue increased.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 32 / 100
Financial Health Score 32/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of LiqTech International, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
31

LiqTech International, Inc. held $5.1M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $6.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and LiqTech International, Inc. scores 31/100 among other emerging companies.

Dilution
30

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. LiqTech International, Inc. scores 30/100 on it among other emerging companies.

R&D Intensity
25

LiqTech International, Inc. spent $1.2M on research and development in fiscal year 2025, which was 4.7% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and LiqTech International, Inc. scores 25/100 among other emerging companies.

Revenue Progress
38

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. LiqTech International, Inc. scores 38/100 on it among other emerging companies.

Burn Trend
32

Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. LiqTech International, Inc. scores 32/100 on it among other emerging companies.

Balance Sheet
34

LiqTech International, Inc.'s cash, cash equivalents and investments came to $5.1M at the end of fiscal year 2025, against $16.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and LiqTech International, Inc. scores 34/100 among other emerging companies.

Altman Z-Score Distress
-4.55

LiqTech International, Inc. scores -4.55, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $94.8M against total assets of $27.3M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

LiqTech International, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

LiqTech International, Inc. reported a net loss of $8.5M while operations used $6.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.4M
YoY+15.5%
QoQ+0.8%
5Y CAGR+1.2%
10Y CAGR+1.8%

LiqTech International, Inc. generated $4.4M in revenue in Q3 2026. This represents an increase of 15.5% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.

EBITDA
-$1.5M
YoYn/m
QoQn/m
5Y CAGRn/m
10Y CAGRn/m

LiqTech International, Inc.'s EBITDA was -$1.5M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$1.8M
YoYn/m
QoQn/m
5Y CAGRn/m
10Y CAGRn/m

LiqTech International, Inc. reported a net loss of $1.8M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
-$890K
YoYn/m
QoQn/m

LiqTech International, Inc. recorded an outflow of $890K in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Shares Outstanding
33M
QoQ0.0%

LiqTech International, Inc. had 33M shares outstanding in Q3 2026. It is unchanged from the prior quarter.

Cash & Debt

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
12.3%
YoY-7.4pp
QoQ+3.9pp
5Y change+7.5pp
10Y change+1.8pp

LiqTech International, Inc.'s gross margin was 12.3% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 7.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.9 percentage points.

Operating Margin
-40.8%
YoY-5.8pp
QoQ+12.6pp
5Y change+22.2pp
10Y change-16.5pp

LiqTech International, Inc.'s operating margin was -40.8% in Q3 2026, reflecting core business profitability. This is down 5.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.6 percentage points.

Net Margin
-41.8%
YoY-4.2pp
QoQ+27.3pp
5Y change+28.3pp
10Y change-16.4pp

LiqTech International, Inc.'s net profit margin was -41.8% in Q3 2026, showing the share of revenue converted to profit. This is down 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 27.3 percentage points.

Return on Equity
-7.6%
YoY+3.6pp
QoQ+4.1pp
5Y change+10.9pp
10Y change-2.5pp

LiqTech International, Inc.'s quarterly ROE was -7.6% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.

Capital Allocation

R&D Spending
$289K
YoY+7.3%
QoQ+6.4%
5Y CAGR-10.3%
10Y CAGR+8.8%

LiqTech International, Inc. invested $289K in research and development in Q3 2026. This represents an increase of 7.3% from the same quarter a year earlier. Against the prior quarter it is up 6.4%.

Capital Expenditures
$18K
YoY-85.8%
QoQ+127.1%

LiqTech International, Inc. invested $18K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 85.8% from the same quarter a year earlier. Against the prior quarter it is up 127.1%.

Share Buybacks

Not reported for Q3 2026.

LIQT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LIQT quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$4.4M+15.5%$4.4M-12.0%$4.1M-10.4%$3.1M-8.2%$3.8M+53.6%$5.0M+10.5%$4.6M+9.0%$3.4M-13.3%
Cost of Revenue$3.9M+26.1%$4.0M-10.6%$3.7M-16.7%$3.2M-17.8%$3.1M+13.8%$4.5M+18.7%$4.5M+13.3%$3.9M+7.6%
Gross Profit$540K-27.8%$366K-24.6%$394K+214.9%-$107Kn/m$748Kn/m$485K-32.4%$125K-53.9%-$528K-293.3%
R&D Expenses$289K+7.3%$272K+12.0%$276K+20.0%$422K+2.4%$269K-3.2%$243K-40.4%$230K-9.7%$412K+43.0%
SG&A Expenses$2.0M+12.9%$2.4M+3.1%$2.4M+15.1%$2.2M+17.9%$1.8M-13.8%$2.4M-1.9%$2.1M+0.9%$1.8M-20.3%
Operating Income-$1.8Mn/m-$2.3Mn/m-$2.3Mn/m-$2.7Mn/m-$1.3Mn/m-$2.1Mn/m-$2.2Mn/m-$2.8Mn/m
EBITDA-$1.5Mn/m-$2.0Mn/m-$1.9Mn/m-$2.3Mn/m-$918Kn/m-$1.7Mn/m-$1.7Mn/m-$2.2Mn/m
Interest ExpenseN/AN/AN/AN/A$63K+83.6%$63K+116.7%$48K-32.7%$32K-45.8%
Income Tax-$370n/m-$370n/m-$377n/m-$380n/m-$375n/m-$360n/m-$339n/m-$187n/m
Net Income-$1.8Mn/m-$3.0Mn/m-$2.7Mn/m-$2.6Mn/m-$1.4Mn/m-$2.2Mn/m-$2.4Mn/m-$3.0Mn/m
EPS (Basic)-$0.05-$0.14-$0.28n/m-$0.27n/m-$0.10n/m-$0.14n/m-$0.25n/m-$0.38n/m

Not reported in any period shown, so not listed: EPS (Diluted), Diluted Shares (Avg).

LIQT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LIQT quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$35.6M+17.6%$37.9M+19.6%$24.9M-21.3%$27.3M-15.9%$30.3M+5.5%$31.7M+11.0%$31.7M+1.1%$32.4M-9.9%
Current Assets$25.8M+37.6%$27.7M+40.0%$14.1M-32.4%$16.0M-22.7%$18.8M+17.6%$19.8M+15.2%$20.9M+7.7%$20.6M-6.6%
Cash & EquivalentsN/AN/A$2.7M$5.1MN/AN/AN/AN/A
Short-Term InvestmentsN/AN/A$0$0N/AN/AN/AN/A
Inventory$5.9M-8.0%$6.0M+8.0%$6.5M+13.4%$6.5M+16.9%$6.4M+2.6%$5.5M-1.9%$5.7M+3.7%$5.5M+5.2%
Accounts Receivable$4.6M+23.0%$5.2M+27.7%$3.7M+6.5%$3.4M+43.2%$3.8M+62.9%$4.1M+46.0%$3.4M+27.1%$2.4M-24.4%
Long-Term InvestmentsN/AN/A$0$0N/AN/AN/AN/A
Goodwill$239K-3.4%$240K-3.0%$243K+6.1%$248K+12.4%$248K+4.7%$248K+9.4%$228K-0.1%$221K-5.6%
Total Liabilities$11.5M-34.5%$12.1M-31.7%$17.4M-0.6%$16.9M+7.2%$17.5M+1.2%$17.8M+9.1%$17.5M+4.0%$15.8M-15.6%
Current Liabilities$6.0M+11.4%$6.3M+15.7%$5.7M+2.8%$4.7M-3.7%$5.4M-10.5%$5.5M-12.4%$5.5M-17.0%$4.9M-34.6%
Non-Current Liabilities$5.5M-54.8%$5.8M-52.8%$11.7M-2.2%$12.2M+12.1%$12.2M+7.5%$12.3M+22.6%$12.0M+17.7%$10.9M-2.9%
Total Equity$24.3M+89.5%$25.9M+86.0%$7.6M-49.4%$10.4M-37.4%$12.8M+12.1%$13.9M+13.5%$15.1M+3.6%$16.7M-3.6%
Retained Earnings-$102.4Mn/m-$100.5Mn/m-$97.5Mn/m-$94.8Mn/m-$92.2Mn/m-$90.8Mn/m-$88.6Mn/m-$86.3Mn/m

Not reported in any period shown, so not listed: Long-Term Debt.

LIQT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LIQT quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$872Kn/m-$3.1Mn/m-$1.9Mn/m-$2.1Mn/m-$1.1Mn/m-$1.6Mn/m-$1.3Mn/m-$2.0Mn/m
Depreciation & Amortization$266K-35.9%$302K-34.3%$357K-19.3%$376K-30.2%$415K-25.1%$459K-12.8%$442K-18.4%$539K-19.5%
Stock-Based CompensationN/AN/A$218K-9.5%N/AN/AN/A$241K+24.8%N/A
Capital Expenditures$18K-85.8%$8K$270K+65.0%$166K-57.4%$127K-65.4%N/A$163K-58.0%$390K-38.3%
Free Cash Flow-$890Kn/m-$3.1M-$2.2Mn/m-$2.3Mn/m-$1.2Mn/mN/A-$1.5Mn/m-$2.4Mn/m
Investing Cash Flow-$18Kn/m$12K-80.6%-$270Kn/m-$45Kn/m-$125Kn/m$63Kn/m-$111K-120.1%-$395Kn/m
Financing Cash Flow-$1.1Mn/m$16.1Mn/m-$309K-131.2%-$68K-100.8%-$69K-107.0%-$133Kn/m$990Kn/m$8.6Mn/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

LIQT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LIQT quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin12.3%-7.4pp8.4%-1.4pp9.5%+6.8pp-3.4%+12.1pp19.6%+28.1pp9.8%-6.2pp2.7%-3.7pp-15.5%-22.4pp
Operating Margin-40.8%-5.8pp-53.4%-10.9pp-55.0%-7.7pp-85.8%-4.6pp-35.0%-42.6%+4.0pp-47.3%+1.0pp-81.2%-22.5pp
Net Margin-41.8%-4.2pp-69.1%-25.7pp-65.5%-14.6pp-83.0%+5.3pp-37.6%-43.4%+3.7pp-50.9%+5.5pp-88.2%-6.5pp
Return on Equity-7.6%+3.6pp-11.6%+3.8pp-35.5%-19.9pp-24.9%-6.8pp-11.2%+13.7pp-15.4%+1.8pp-15.6%+0.8pp-18.0%+0.6pp
Return on Assets-5.2%-0.4pp-8.0%-1.2pp-10.9%-3.5pp-9.5%-0.2pp-4.7%+5.2pp-6.8%+0.6pp-7.4%+0.2pp-9.3%-0.3pp
Current Ratio4.32+0.8x4.37+0.8x2.50-1.3x3.38-0.8x3.50+0.8x3.61+0.9x3.80+0.9x4.21+1.3x
Liabilities-to-Equity0.47-0.9x0.47-0.8x2.28+1.1x1.62+0.7x1.37-0.1x1.28-0.1x1.160.0x0.95-0.1x
Asset Turnover0.120.0x0.120.0x0.170.0x0.110.0x0.130.0x0.160.0x0.150.0x0.110.0x
FCF Margin-20.3%+11.2pp-71.1%-53.5%-21.8pp-73.5%-3.2pp-31.4%+53.9ppN/A-31.6%+23.8pp-70.3%-23.5pp

Not reported in any period shown, so not listed: Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
LiqTech International, Inc. LIQT FY2025 $16.5M -$8.5M -51.7% $6.4M 32/100
Rain Enhancement Technologies Holdco, Inc. RAIN FY2025 N/A -$9.1M N/A $8.5M —
Euro Tech Holdings Co Ltd. New CLWT FY2025 $13.3M $167K 1.3% $7.8M 35/100
ClearSign Technologies Corporation CLIR FY2025 $5.2M -$5.5M N/A $10.2M 55/100
Birchtech Corp. BCHT FY2025 $17.6M -$3.0M -17.2% $20.4M 43/100
374Water Inc. SCWO FY2025 $215K -$21.0M N/A $31.2M —

Frequently Asked Questions

LiqTech International, Inc. (LIQT) reported $16.5M in total revenue for fiscal year 2025. This represents a 13.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

LiqTech International, Inc. (LIQT) revenue grew by 13.0% year-over-year, from $14.6M to $16.5M in fiscal year 2025.

No, LiqTech International, Inc. (LIQT) reported a net loss of $10.2M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $8.5M, with a net profit margin of -51.7%.

LiqTech International, Inc. (LIQT) had EBITDA of -$6.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

LiqTech International, Inc. (LIQT) had a gross margin of 7.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

LiqTech International, Inc. (LIQT) had an operating margin of -50.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

LiqTech International, Inc. (LIQT) had a net profit margin of -51.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

LiqTech International, Inc. (LIQT) has a return on equity of -81.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

LiqTech International, Inc. (LIQT) recorded an outflow of $6.5M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

LiqTech International, Inc. (LIQT) recorded an outflow of $6.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

LiqTech International, Inc. (LIQT) had $27.3M in total assets as of fiscal year 2025, including both current and long-term assets.

LiqTech International, Inc. (LIQT) invested $395K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

LiqTech International, Inc. (LIQT) invested $1.2M in research and development during fiscal year 2025.

LiqTech International, Inc. (LIQT) had 10M shares outstanding as of fiscal year 2025.

LiqTech International, Inc. (LIQT) had a current ratio of 3.38 as of fiscal year 2025, which is generally considered healthy.

LiqTech International, Inc. (LIQT) had a liabilities-to-equity ratio of 1.62 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

LiqTech International, Inc. (LIQT) had a return on assets of -31.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

LiqTech International, Inc. (LIQT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $6.4M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

LiqTech International, Inc. (LIQT) trades at 0.4x sales, its market capitalization divided by $16.0M revenue, trailing 12 months to September 30, 2026. The market capitalization is $6.4M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, LiqTech International, Inc. (LIQT) held $5.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $6.1M over that year. Dividing the one by the other, the reported balance equals about 10 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

LiqTech International, Inc. (LIQT) has an Altman Z-Score of -4.55, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

LiqTech International, Inc. (LIQT) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

LiqTech International, Inc. (LIQT) reported a net loss of $8.5M while operations used $6.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

LiqTech International, Inc. (LIQT) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top